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Zinc supplementation is recommended in all acute diarrheas in children from developing countries. We aimed to assess whether
zinc supplementation would be equally eﬀective against all the common organisms associated with acute diarrheas. We used data
on 801 children with acute diarrhea recruited in a randomized, double blind controlled trial (ISRCTN85071383) of zinc and
copper supplementation. Using prespeciﬁed subgroup analyses, multidimensionality reduction analyses, tests of heterogeneity,
and stepwise logistic regression for tests of interactions, we found that the inﬂuence of zinc on the risk of diarrhea for more
than 3 days depended on the isolated organism—beneﬁcial in Klebsiella,n e u t r a li nEsherichia coli and parasitic infections, and
detrimental in rotavirus coinfections. Although we found similar results for the outcome of high stool volume, the results did not
reach statistical signiﬁcance. Our ﬁndings suggest that the current strategy of zinc supplementation in all cases of acute diarrheas
in children may need appropriate ﬁne tuning to optimize the therapeutic beneﬁt based on the causative organism, but further
studies need to conﬁrm and extend our ﬁndings.
1.Introduction
In 2004, the World Health Organization (WHO) and the
United Nations Children’s Fund (UNICEF) recommended,
in a joint statement, the use of zinc supplementation for
the treatment of acute diarrhea in developing countries [1].
This recommendation was based on strong biological and
epidemiological evidence which suggested that zinc sup-
plementation can signiﬁcantly reduce the overall duration
of diarrhea and is also likely to reduce stool volume and
frequency[2].However,thereexistssigniﬁcantheterogeneity
in the eﬀects of zinc on diarrhea-related outcomes observed
across published randomized controlled trials [3–5]. Poten-
tial contributors to this heterogeneity are currently not fully
understood.
There is some evidence to suggest that the beneﬁcial
eﬀect of zinc may not be equivalent against the common
causative organisms. Roy et al. [6]h a dﬁ r s td e m o n s t r a t e d
that the extent to which mucosal permeability is aﬀected in
diﬀerent diarrheas depends on the causative organisms—in
general, diarrheas caused by invasive organisms show higher
permeability. Second and consistent with this observation,
Canani et al. [7] observed that zinc-induced promotion of
ion absorption across the gut is evident in response to the
ion secretion caused by Vibrio cholerae toxin but not the
Escherichia coli heat-stable enterotoxin. Third, Surjawidjaja
et al. [8] showed that although zinc sulphate can inhibit the
growth of enteropathogens in vitro, the lethal dose required
to kill 50% of the organisms (LD50) widely varies across
the species of the causative organisms. Consequently it is
possible that the overall beneﬁcial eﬀect of zinc supplemen-
tation observed in a trial may depend on the spectrum of the
causative organisms within that study. The inﬂuence of zinc
supplementation on diarrhea could thus be dependent on2 International Journal of Pediatrics
the organisms present in the gut. Using microbiological and
clinical data from a three-arm randomized controlled trial
of zinc supplementation, we therefore determined whether
diﬀerential organisms can partially contribute to the eﬀect of
zinc. Due to limited resources, we were unable to conduct
serotyping for pathogenic organisms causing diarrhea. In
this report, therefore, we demonstrate the modulation of
eﬀect of zinc supplementation by bacterial isolates in the
stool and rotavirus infection.
2. Patientsand Methods
2.1. Study Subjects. This dataset comes from a double-blind,
randomized, placebo-controlled clinical trial in children
aged 6–59 months attending the Indira Gandhi Government
Medical College and Hospital, in Nagpur, India with >3
unformed stools in the prior 24 hours; duration of diarrhea
<72 hours; and ability to accept oral ﬂuids or feeds. Details
about the study subjects, the trial design, and its rationale are
provided elsewhere [9]. Brieﬂy, all children aged 6 months
to 59 months attending study center with more than three
unformedstoolsintheprior24hourswithatotaldurationof
diarrhea at recruitment of up to 72 hours and who were able
toacceptoralﬂuidswererecruitedinthestudy.Theexclusion
criteria were chronic or severe complicating illness, known
positive HIV status, kwashiorkor, residing outside a radius of
30km around the hospital, participating in another study, or
already enrolled in this study. The trial is registered with the
InternationalStandardRandomized ControlledTrialregister
with the unique identiﬁer ISRCTN85071383. The Ethics
Committee of Indira Gandhi Government Medical College,
Nagpur, and the Human Research Ethics Committee of the
University of Newcastle, New South Wales, Australia (HREC
Approval no: H-500-0203) approved the study protocol and
the treatment eﬀects monitoring committee monitored the
trial for safety.
2.2. Study Protocol. Each recruited child was sequentially
assigned to one of the following three treatment arms using
a randomization protocol ﬁxed a priori: placebo (Pl, n =
271) arm, zinc (Zn, n = 264) only arm, and zinc and
copper (Zn + Cu, n = 273) arm. Participants in the Zn
arm received the therapeutic dose 2mg/kg/day of zinc while
participants in the Zn + Cu arm received the same dose
of zinc as well as 0.2mg/kg/day of copper. Microbiological
investigations were conducted with a sterile container having
a plastic spoon attached to the inside of the screw cap for
stool collection. The fecal sample ﬁrst underwent a naked
eye examination for consistency, presence of mucous and
blood. In the laboratory, the sample underwent gross and
microscopic examination of wet and iodine preparations.
Kenyon’s method of acid fast staining for parasitic cyst was
also done. For bacterial isolation sample was inoculated on
sheep blood agar, MacConkey Bile Salt Agar, selenite F broth,
Skirrow’s campylobacter medium, alkaline peptone water,
and thiosulphate citrate bile salts agar. The bacterial iso-
lates were identiﬁed by standard bacteriological techniques
[10]. Enzyme-linked immunosorbent assay (ELISA; Premier
Rotaclone, Meridian Bioscience, Inc, Cincinnati, OH) was
used for rotavirus antigen detection.
2.3. Outcomes and Predictors. In this study we examined
whether zinc supplementation either alone or in combi-
nation with copper was associated with improvement in
two diarrhea-related outcomes—the likelihood of continued
diarrhea beyond 3 days since initiation of therapy, and
the volume of stool collected during hospital stay. This
latter outcome was divided into two categories based on
the median stool volume in the study subjects. This study
was conducted as a set of prespeciﬁed subgroup analyses
that speciﬁcally aimed to tease out possible heterogeneity
of zinc supplementation eﬀects across the spectrum of the
organisms isolated from stools.
2.4. Statistical Analyses. We followed the existing guidelines
for reporting subgroups analyses from randomized con-
trolled trials [11, 12]. Recognizing that the interpretations
and recommendations based on subgroups analyses heavily
depend on a critical and careful statistical analysis, we
conducted our analyses in two steps.
In the ﬁrst step, we attempted to establish that our
analyseswillhavesuﬃcientstatisticalpowerwhileaddressing
the issues of multiple comparisons and of treatment (zinc) ×
modiﬁer (isolated organisms) interactions. For this we used
the following three complementary analytical techniques.
(a) The ﬁrst is the method of multifactor dimensionality
reduction (MDR) [13] to examine the likely interactions
among isolated organisms and zinc supplementation for the
two diarrhea related organisms. MDR is a nonparametric,
exploratory approach that identiﬁes and characterizes the
potentialinteractionsinalargenumberofdiscretepredictors
with a binary outcome and is commonly used to identify
gene-gene interactions. (b) We next looked for signiﬁcant
bivariate interaction of each major isolated organism with
zinc supplementation for both the outcomes. For this, we
used the interaction contrast statistic (Δ)d e s c r i b e db y
G¨ onen [14]. We tested the statistical signiﬁcance of this
interaction using the Breslow-Day test for heterogeneity and
also determined the statistical power of our study to make
inferences about these interactions. To estimate the power
we made use of the θ statistic [14]. This was estimated
using the arcsine transformation as 2sin
−1(p1/2)w h e r ep is
proportionofsubjectsdevelopingtheoutcomeofinterestfor
a given combination of the therapy received and the isolated
organism. The θ statistic has a standard normal distribution
with variance 1/n,w h e r en is the number of observations.
(c) We next conducted stepwise multiple logistic regression
analysis [15] for each outcome where the primary objective
was to arrive at a reduced list of signiﬁcant interactions
based on the organisms identiﬁed in step (b). For stepwise
regression we used the backward elimination strategy with a
conventional probability retention criterion of 0.2. In the full
model, we considered the main eﬀects and all interactions
(bivariate as well as higher-order) among the therapy and
diarrheal isolates. One cardinal issue in subgroup analyses is
the multiplicity of comparisons. To address this, we countedInternational Journal of Pediatrics 3
the total number of comparisons and reported the likelihood
of false positive identiﬁcation of signiﬁcant interactions.
In the second step of the analysis, we aimed to test the
robustness of our ﬁndings in the light of possible corre-
lations with other predictors of zinc eﬀectiveness. In this
step, we used multivariate unconditional logistic regression
modeling. In these multivariate models we adjusted for
the following covariates: age, gender, presence of stunting
(weight-for-age z-score < −2), presence of wasting (length-
for-age z-score < −2), wealth index score, hand washing
score, baseline plasma zinc level, baseline plasma copper
level, and baseline hemoglobin level. Statistical signiﬁcance
was examined at a type I error rate of 0.05.
MDR analysis used the MDR software (http://source-
forge.net/projects/mdr/). All other analyses were conducted
using Stata 10.2 (Stata Corp, College Station, TX) software
package.
3. Results
3.1. Description of Outcomes and Predictors. Of the total
808 study subjects, microbiological data was available for
801 (99.1%) children. From these 801 children a total of
913 organisms were isolated—548 (68.4%) children had a
single organism isolated, 195 (24.3%) children had mixed
isolates with at least 2 organisms, while no organisms
could be isolated in 58 (7.3%) children. In the order
of commonness the following organisms were isolated in
the study subjects: E. coli 451 (56.3%), Klebsiella spp 276
(34.5%), rotavirus169 (21.1%), parasitic ova and cysts in
stool 121 (15.1%), Shigella spp 8( 1 % ) ,Salmonella spp 5
(0.6%), and Campylobacter jejuni 2 (0.2%). Interestingly, of
the 169 children with rotavirus infection, E. coli-rotavirus
combination was observed in 100. At baseline, children with
weight for age < −2 z-score were 19%, 57.5%, and 32.7% in
those with rotavirus infection, E.coli and Klebsiella isolates
in the stool samples. Correspondingly the proportions
with serum zinc <60μg/dl were 25.2%, 56.4%, and 35%,
respectively. Adherence to supplementations was similar in
the three groups at 92.2%, 90.4%, and 88%, respectively.
Three hundred and six (38.2%) children had diarrhea that
extended beyond 72 hours after initiation of therapy. The
median stool volume for all the study subjects was 685ml.
Based on this cut-oﬀ we dichotomized the study children in
to those who had low stool volume (<685ml) and those who
had high stool volume (≥685ml).
3.2. Interactive Eﬀects among Isolated Organisms and Zinc
Supplementation. We ﬁrst conducted MDR analyses to
identify and characterize potential interactions among zinc
supplementation and four major isolates: E. coli, Klebsiella,
rotavirus, and parasites. Our results indicated (Figure 1)
that for the outcome of diarrhea >3d a y sE. coli was not
found to be contributory to any interaction while Klebsiella
was noncontributory to the outcome of high stool volume.
Presenceofrotaviruswasassociatedwithahigherproportion
of children with diarrhea >3 days especially when they
received zinc supplementation as indicated by taller red bars
in cells 4, 8, and 12 in Figure 1. On the other hand, when
Klebsiella but not rotavirus was isolated from the stools, zinc
supplementation appeared to be associated with a reduced
likelihoodofdiarrhea>3days(comparetheredandbluebars
in cells 6, 13, and 14 of Figure 1). Although MDR included
parasites as another potential source of interactions for the
outcome of diarrhea >3 days, its role did not appear to be
deﬁnitive. Using this set interactions identiﬁed by MDR, its
odds ratio for accurate prediction of the outcome was 2.34
(95% CI 1.73–3.17, P = 2.6 ×10
−8) with an overall accuracy
of 63.1%. For the outcome of high stool volume, MDR
analysis again identiﬁed presence of rotavirus as a potential
deterrenttothebeneﬁcialeﬀectofzinc(magentabarsincells
4, 8, 12, and 16 in Figure 1). In general, presence of E. coli in
the stool was associated with an increased risk of high stool
volume (magenta bars in cells 7, 8, and 13–16 in Figure 1).
Again the role of parasites, although identiﬁed by MDR as a
possible dimension, was equivocal. For this outcome, the OR
for correct prediction based on MDR results was 2.33 (95%
1.73–3.14, P = 1.7×10
−8)withanoverallaccuracyof59.4%.
We next examined the bivariate interactions between
each of the major isolates and zinc supplementation for
both the outcomes (Figure 2). For diarrhea >3 days, the
interaction constant was positive for E. coli and rotavirus,
signiﬁcantly negative for Klebsiella, and uninformative for
parasites. This indicated that zinc supplementation may
provide detrimental results in the presence of E. coli and
rotavirus but may be associated with a shorter period of
diarrhea in the case of Klebsiella isolates. The Breslow-
Day test also identiﬁed E. coli, rotavirus, and Klebsiella
to be interacting signiﬁcantly with zinc supplementation
for this outcome. As shown in Figure 2 (grey bars) our
study had moderate to suﬃcient power to detect signiﬁcant
interactions. Although similar directionality for interactions
was also observed for the outcome of high stool volume,
statistical signiﬁcance as well as suﬃcient power was only
achieved for the E. coli isolates. Since parasites did not
demonstrate any signiﬁcant interaction with zinc supple-
mentation and had negligible statistical power for either of
the outcomes, we omitted this source of interaction from all
further analyses.
Lastly, we considered the importance of the interactions
in a multivariate context. We studied four main eﬀects (zinc,
E. coli, Klebsiella, and, rotavirus), six bivariate interactions
(listedascovariates5through10inFigure3),andfourthree-
way interactions (covariates 11 through 14 in Figure 3). To
control for multiple comparisons in this step of the analysis
we employed the method of stepwise logistic regression
with a conventional retention criterion of 0.2. In the ﬁnal
models,weobservedthatfortheoutcomeofdiarrhea>3days
zinc supplementation provided two statistically signiﬁcant
and directionally opposite interactions: with rotavirus and
(OR > 1) and with Klebsiella (OR < 1). In contrast, for
the outcome of high stool volume there were two synergistic
and signiﬁcant interactions of zinc supplementation: with
E. coli and with rotavirus (both OR > 1). Thus, there
were four signiﬁcant interaction terms that involved zinc
supplementation in our stepwise multivariate regression
procedure. As shown in Figure 3, there were a total of 104 International Journal of Pediatrics
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Figure 1:Investigationintotheinteractionofisolatedorganismswiththeeﬀectofzincontwodiarrhea-relatedoutcomes—riskofcontinued
diarrhea for 3 or more days (left column) and high stool volume (right column) based on the results from multifactor dimensionality
reduction (MDR) analyses. Results show the proportion of subjects with (red and magenta bars) and without (blue and green bars) the
indicated outcome for a given combination of zinc supplementation and isolated organisms. The background of each cell representing a
speciﬁc combination is gradient, coded as shown in the key at the bottom of the MDR grid. Numbers at the top of the bars are proportions
and numbers in yellow are cell identiﬁers.
Bivariate interactions of isolates with zinc supplementation
Outcome: diarrhea for > 3d a y s O u t c o m e :h i g hs t o o lv o l u m e
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Figure 2: Statistical evaluation of the bivariate interactions between zinc supplementation and each of the four major isolates for two
diarrhea-related outcomes—risk of continued diarrhea for 3 or more days (left column) and high stool volume (right column). The
interaction was quantiﬁed using the interaction contrast statistic [14], the signiﬁcance was tested using the Breslow-Day (B-D P) test for
heterogeneity, and statistical power of interpretation in the present study was determined using the θ statistic described by G¨ onen [14].
Interaction contrast exceeding or below zero indicates a detrimental or protective interaction, respectively.International Journal of Pediatrics 5
Multivariate evaluation of interactions among the isolates and zinc supplementation
Outcome: diarrhea for > 3d a y s O u t c o m e :h i g hs t o o lv o l u m e
Covariates Results from full model Results from full model Results from ﬁnal model Results from ﬁnal model
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Figure 3: Multivariate association of main and interactive eﬀects of zinc supplementation and diarrheal isolates using stepwise logistic
regression models for two diarrhea-related outcomes—risk of continued diarrhea for 3 or more days (left column) and high stool volume
(right column). In this grid, yellow background indicates the main eﬀects, black circle indicates the included covariate, the blue background
indicates interactive eﬀects, and black circles in the blue part of the grid indicate the interactions among the circled covariates. Z: zinc
supplementation; E: Escherichiacoli;K :Klebsiella; and R: rotavirus. Diamonds and error bars indicate the point and 95% conﬁdence interval
estimates for the log odds ratio (Log OR). Results are from full model (on the left) and ﬁnal model (on the right) from the stepwise logistic
regression analyses. The full model included all the 14 covariates indicated in the grid while the stepwise regression analyses used a backward
elimination strategy with a probability retention criterion of 0.2. Numbers at the right-hand side in the ﬁnal model plots are signiﬁcance
values for the covariates that were retained in the ﬁnal model.
interaction terms in the full model for each outcome, and
thus,atotalof20interactionswereconsideredintheanalysis.
At a type I error rate of 0.05, this would mean that one of the
signiﬁcant interactions detected in our study is likely to be a
false positive.
3.3. Robustness of Treatment Heterogeneity: Multivariate
Models. Wenextsetouttoinvestigatewhetherthesigniﬁcant
interactions observed held the signiﬁcance in the face of
several other potential contributors to the two outcomes.
Consistent with our previous observations [9], we found
that zinc supplementation either alone or in combination
with copper supplementation did not inﬂuence either of the
study outcomes after adjusting for baseline covariates (rows
titled “Overall” in Tables 1 and 2). We conducted a series
of multivariate logistic regression models that included the
aforementioned covariates.
For the outcome of continued diarrhea >3d a y s ,w e
observed that zinc supplementation had a strikingly protec-
tive eﬀect when Klebsiella was isolated, no eﬀect when single
E. coli or intestinal parasites were isolated, but a high risk of
the outcome when rotavirus was isolated and an even higher
likelihood (3.39 times) of prolonged diarrhea when E. coli
were isolated along with rotavirus. Moreover, the protective
eﬀect in the context of Klebsiella isolates was nulliﬁed when
rotavirus isolates were simultaneously found. Notably, we
observedtheprotectiveeﬀectsofzincsupplementation when
Klebsiella was isolated and the detrimental eﬀects of zinc
supplementation in E. coli-rotavirus infections were boosted
by the addition of copper. We found similar results when
we used other cut-points for dichotomizing the diarrheal
duration like 5 days and 7 days (data not shown). Thus,
the inﬂuence of zinc supplementation on the proportion
of subjects with prolonged diarrhea was substantially mod-
ulated by the micro-organisms isolated. For the outcome
of high stool volume we observed similar eﬀects; however,
in most instances the observations did not reach statistical
signiﬁcance (Table 2).
4. Discussion
There are four-key ﬁndings of this study. First, the beneﬁcial
eﬀect of zinc supplementation in acute diarrhea was not
equal against all organisms isolated from stools. Of special
concern,however,wasourobservationthatzincmayactually
increase the risk of prolonged diarrhea in the presence of E.
coli-rotavirus (prevalence of 12% in this study). Prescreening
for rotavirus reactivity may enhance the utility of zinc
supplementation by restricting it to subjects not reactive
to rotavirus. It is interesting to note that two studies in
young infants in four countries (Bangladesh, Ethiopia, India,
and Pakistan) showed no eﬀect of zinc supplementation on6 International Journal of Pediatrics
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Table 2: Inﬂuence of zinc supplementation on the outcome of high stool volume in diﬀerent subgroups based on the isolated organisms.a
Subgroup N Zn verses Pl Zn+ Cu verses Pl Any zincb verses Pl
OR
c 95% CI P OR 95% CI P OR 95% CI P
Overall 798 0.88 0.62–1.26 .496 0.88 0.62–1.25 .472 0.88 0.65–1.20 .418
E. coli infection 449 1.17 0.72–1.89 .519 1.41 0.87–2.26 .159 1.29 0.85–1.95 .236
E. coli single infection 273 0.97 0.52–1.81 .922 1.20 0.65–2.22 .560 1.08 0.63–1.86 .776
Klebsiella infection 275 0.67 0.36–1.24 .204 0.55 0.30–1.03 .062 0.61 0.36–1.04 .071
Klebsiella single infection 170 0.70 0.31–1.58 .395 0.48 0.21–1.08 .077 0.58 0.29–1.18 .131
Rotavirus infection 169 1.44 0.62–3.39 .398 2.31 0.99–5.39 .052 1.85 0.89–3.84 .097
E. coli + rotavirus mixed infection 100 1.19 0.35–4.00 .781 2.44 0.72–8.27 .151 1.74 0.59–5.09 .313
Klebsiella + rotavirus mixed infection 53 0.92 0.14–6.08 .930 2.09 0.37–11.9 .408 1.51 0.32–7.07 .601
aAll the results are from multivariate logistic regression analyses which adjusted for eﬀects of age, gender, presence of stunting (weight-for-age z-score < −2),
presence of wasting (length-for-age z-score < −2), wealth index score, hand washing score, baseline plasma zinc level, baseline plasma copper level, and
baseline hemoglobin level.
bChildren receiving zinc alone or zinc and copper compared to those receiving placebo.
cOR: odds ratio; CI: conﬁdence interval; N: number of subjects with complete covariate information; Zn: zinc, Zn + Cu: zinc and copper; Pl: placebo.
duration of acute diarrhea. Rotavirus is known to be the
commonest causative organism in breast fed young infants,
and although the authors acknowledge that it could be
the reason for failure of zinc eﬀect, it was not assessed
in any of these studies [16, 17]. The only other random-
ized controlled trial [18] that has conducted a subgroup
analysis based on the presence or absence of rotavirus
in diarrhea concurs with our ﬁnding that the beneﬁcial
eﬀect of zinc could not be observed in rotavirus-infected
children. Diarrhea in rotavirus infection may be caused by
several mechanisms, namely, enterocyte destruction, villus
ischaemia, activation of enteric nervous system by release
of vasoactive agents, and intestinal secretion by intracellular
and extracellular action of nonstructural protein (NSP4)
whichstimulatesCa++ dependantcellpermeability[19].The
action of zinc supplementation on these mechanisms is
currently unknown. Our ﬁndings suggest that in rotavirus
infected children zinc should be used cautiously. Our results
also gain operational importance since in many situations
it may not be feasible to conduct microbiological studies in
deciding the value of zinc supplementation in children with
acute diarrhea.
Second, in children from whom the commonest organ-
ism (E. coli) in the present study was isolated, zinc supple-
mentation showed no signiﬁcant association with the length
of diarrhea or stool volume. This is despite the fact that
this group had the highest proportion of wasted children,
had serum zinc <60μg/dl, and most could thus be expected
to beneﬁt from zinc supplementation. Including this study,
two other trials [20, 21]—both from India—had found that
E. coli was the commonest stool isolate in children with
diarrhea. One of these studies [21] found no signiﬁcant
impact of zinc supplementation on diarrheal duration while
the other study [20] found a signiﬁcant beneﬁt but had used
a high dose (40mg/Kg/d) of elemental zinc. This ﬁnding
is interesting in the light of the observation [8] that a
higher concentration of zinc sulphate is needed in vitro to
inhibit the enteropathogenic strains of E. coli. Together these
observations suggest that the possibility of higher dose zinc
supplementation should be considered when E. coli is the
probable cause of diarrhea. Our ﬁndings along with those
of Surjawidjaja et al. [8], Dutta et al. [20], and Sachdev et
al. [21] also raise an interesting possibility that an optimum
dose of zinc may be beneﬁcial against most of the causative
organisms and that a possible future direction to take would
be to design studies focused on the dose-response to zinc
supplementation. It should be remembered however that in
vitro, ex vivo, or in vivo beneﬁt of zinc supplementation in
rotavirus diarrheas is currently unstudied and unknown.
Third, although mechanistically unclear, our results
suggest that Klebsiella-associated diarrheas may be more
responsive to zinc supplementation. Klebsiella enterotoxins
cause reduced Na absorption and net Cl
− secretion in
rabbit ileum by increasing cGMP. Although the addition
of zinc does not aﬀect cGMP-mediated ion secretion, zinc
may still have a protective eﬀect that is associated with
its action on basal ion transport [7]. It is well recognized
that the enteroaggregative patterns exhibited by Klebsiella
spp and their heat-stable enterotoxins are structurally and
functionally distinct from those of E. coli and chieﬂy induce
diarrhea by chloride ion depletion [22, 23]. Since it has been
shown that zinc can speciﬁcally inhibit the luminal secretion
of the chloride ion [7, 24], it is likely that the Klebsiella-
induced diarrhea is amenable to zinc supplementation.
Considering the similarity in the mechanism of diarrhea
causation it is conceivable that zinc supplementation may
also be very useful in cholera—a premise that is strongly
supported by in vitro and epidemiological observations [7,
25]. Finally, our results shown in Table 2 indicated that the
signiﬁcant interactions observed for the outcome of high
stool volume may likely have been false and could have
originatedfromthecomplexcorrelationstructureamongthe
covariates that better predicted the outcome. This reiterates
the general view that zinc supplementation has a more
signiﬁcanteﬀectonthediarrhealdurationratherthanonthe
volume of stool.
We believe that the limitations of this study must be
recognized before a generalization of the results can be
undertaken. First, we did not have the resources to serotype
the organisms isolated in the stools. Consequently, it cannot8 International Journal of Pediatrics
be presumed that the isolated organisms would necessarily
indicate a causal association with the diarrhea episode.
Nevertheless we could demonstrate a diﬀerential response in
rotavirus infection and in the presence of diﬀerent bacterial
organisms in the gut regardless of the fact that some may not
have been pathogenic. Second, this study only had statistical
power in excess of 60% which can be considered as suﬃcient
butnotveryhigh.Thus,replicationandsubstantiationofour
ﬁndings in larger and more statistically powerful studies is
needed. Third, our ﬁndings are essentially epidemiological.
Whether they readily translate to bedside management
cannot be forecast in the absence of more direct mechanistic
studies. This study suggests that more research is needed
to understand the eﬀect of zinc supplementation on acute
diarrhea due to diﬀerent causative pathogens. Therefore
we suggest that zinc eﬃcacy trials should now include a
more complete assessment of the causative organisms at
baseline. Fourth, microbiological prescreening prior to zinc
supplementation in resource-limited countries is unlikely
to be feasible. Thus, future studies should address this
important area of interventional feasibility.
5. Conclusion
There is now a growing recognition that the beneﬁcial
eﬀects of zinc supplementation may not be universal [9, 26].
Although we did not have data on further typing of the
isolates in this study, our ﬁndings suggest that the universal
strategy of zinc supplementation regardless of the organism
isolated in the stool may be an oversimpliﬁcation. If our
results are indeed pointing towards a true diﬀerential beneﬁt
of zinc supplementation by the causative organisms, then
more care will be required in recommending an optimum
dose of zinc that is most beneﬁcial as it will depend on the
diﬀerential LD50 values [6] and the relative prevalence of
the microbes included in the causative spectrum of acute
diarrhea.
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